Number of new U.S. drug shortages hits lowest level in 20 years
The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly…
Slingshot pulls therapy chatbot Ash out of UK over regulatory concerns
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
We’re reading about Canada speeding drug reviews, Novo ads
Rise and shine, everyone, another busy day is headed your way. And it is getting off to a…
More patients are ordering lab tests online, frustrating some doctors
About a decade ago, 48-year-old Darren Sidaway started having health concerns he didn’t think he could bring to…
Neuralink’s big vision collides with reality of brain implants
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming…
Pharma’s ‘Dr. Optimistic’ is worried about the industry’s future
In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview me about…
FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
Regulatory reform can unlock access to biosimilars
Every day, I think about the patients waiting for medicines that could change, or even save, their lives.…
U.K. pledges to boost pharma payments, will avoid U.S. tariffs on drugs
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
FDA reviewers didn’t get to vote on first priority voucher drug
WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…